| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |